In addition, protein levels of AMPKα1 and pAMPK (T172) were higher in most cancer samples compared with that in paired nontumorous tissues (Fig. 1d), which was further validated with immunohistochemistry assays (Fig. 1e). This evidence concerns the gene PRKAA1 and cancer.